Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2007-06-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.0703867104PMID 17548809PMCID PMC1891231
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of a flexible and potent hypoxia-inducible promoter for tumor-targeted gene expression in attenuated salmonella

  2006cited by this paper
• A Bacterial Protein Enhances the Release and Efficacy of Liposomal Cancer Drugs

  2006cited by this paper
• Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice.

  2006cited by this paper
• Real‐time whole‐body imaging of an orthotopic metastatic prostate cancer model expressing red fluorescent protein

  2005cited by this paper
• Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium.

  2005cited by this paper
• Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins

  2004cited by this paper
• Cellular Dynamics Visualized in Live Cells in Vitro and in Vivo by Differential Dual-Color Nuclear-Cytoplasmic Fluorescent-Protein Expression

  2004cited by this paper
• Bacteriolytic therapy can generate a potent immune response against experimental tumors.

  2004cited by this paper
• Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria

  2003cited by this paper
• Optical imaging: bacteria, viruses, and mammalian cells encoding light-emitting proteins reveal the locations of primary tumors and metastases in animals

  2003cited by this paper
• Secretory delivery of recombinant proteins in attenuated Salmonella strains: potential and limitations of Type I protein transporters.

  2003cited by this paper
• Bacteria as tumour-targeting vectors.

  2003cited by this paper
• Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma.

  2002cited by this paper
• Bifidobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors

  2001cited by this paper
• Spatial–temporal imaging of bacterial infection and antibiotic response in intact animals

  2001cited by this paper
• Combination bacteriolytic therapy for the treatment of experimental tumors

  2001cited by this paper
• Use of preferentially replicating bacteria for the treatment of cancer.

  2000cited by this paper
• Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium.

  2000cited by this paper
• Bifidobacterium longum as a delivery system for cancer gene therapy: Selective localization and growth in hypoxic tumors

  2000cited by this paper
• Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivo

  1999cited by this paper
• The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.

  1998cited by this paper
• Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment

  1997cited by this paper
• Tumor-targeted Salmonella as a novel anticancer vector.

  1997cited by this paper
• Anaerobic bacteria as a delivery system for cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered clostridia.

  1996cited by this paper
• Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines

  1981cited by this paper
• Selective localization and growth of Bifidobacterium bifidum in mouse tumors following intravenous administration.

  1980cited by this paper
• Antitumor effect of Bifidobacterium infantis in mice.

  1978cited by this paper
• Clostridial oncolysis in man

  1967cited by this paper
• ONCOLYSIS BY CLOSTRIDIA. II. EXPERIMENTS ON A TUMOR SPECTRUM WITH A VARIETY OF CLOSTRIDIA IN COMBINATION WITH HEAVY METAL.

  1964cited by this paper
• ONCOLYSIS BY CLOSTRIDIA. I. ACTIVITY OF CLOSTRIDIUM BUTYRICUM (M-55) AND OTHER NONPATHOGENIC CLOSTRIDIA AGAINST THE EHRLICH CARCINOMA.

  1964cited by this paper
• ONCOLYSIS BY CLOSTRIDIA. III. EFFECTS OF CLOSTRIDIA AND CHEMOTHERAPEUTIC AGENTS ON RODENT TUMORS.

  1964cited by this paper
• Localization of the vegetative form of Clostridium tetani in mouse tumors following intravenous spore administration.

  1955cited by this paper
• Effect of Histolyticus Infection and Toxin on Transplantable Mouse Tumors.∗

  1947cited by this paper

• Attenuated Bacteria-Based Tumor Therapy: Clinical Application Risks, Marketing Approval Restrictions, and Coping Strategies.

  2026cites this paper
• Genetically Modified Salmonella typhimurium: A Trojan Horse Strategy for Targeted Cancer Therapy

  2026cites this paper
• Immunological Aspects of Mucosal Vaccine-Based Bacterial-like Particles (BLPs) - An updated review.

  2025cites this paper
• Thirty Years of Mentoring by “Bob Chan” of Young Japanese Surgeons to Become Scientists: An Adventure of Love

  2025cites this paper
• Salmonella-Induced Cell Death in Cancer Immunotherapy: What Lies Beneath?

  2025cites this paper
• Applications of Nanomaterial‐Microorganism Hybrid Systems in the Treatment of Tumor

  2025cites this paper
• Engineered Methioninase‐expressing Tumor‐targeting Salmonella typhimurium A1‐R Inhibits Syngeneic‐Cancer Mouse Models by Depleting Tumor Methionine

  2025cites this paper
• Living Bacteria: A New Vehicle for Vaccine Delivery in Cancer Immunotherapy

  2025cites this paper
• Glutathione-responsive self-assembling peptide coated Salmonella for antitumor therapy.

  2025cites this paper
• Engineered Bacteria-Nano Hybrid System: The Intelligent Drug Factory for Next-Generation Cancer Immunotherapy

  2025cites this paper
• Dynamic Fluorescence Imaging of Orally-administered Tumor-targeting Salmonella typhimurium A1-R Expressing Green Fluorescent Protein Trafficking Through the Gastrointestinal System to Target Fibrosarcomas in Nude Mice

  2025cites this paper
• Bacteria-Based Nanoprobes for Cancer Therapy

  2024cites this paper
• Accurate and Safe Tumor Targeting of Orally-administered Salmonella typhimurium A1-R Leads to Regression of an Aggressive Fibrosarcoma in Nude Mice

  2024cites this paper
• Synergistic Brilliance: Engineered Bacteria and Nanomedicine Unite in Cancer Therapy

  2024cites this paper
• The Combination of Tumor-targeting Salmonella typhimurium A1-R Plus the Autophagy-inhibitor Chloroquine Synergistically Eradicates HT1080 Fibrosarcoma Cells In Vitro and In Vivo

  2024cites this paper
• Advances in bacteria‐based drug delivery systems for anti‐tumor therapy

  2024cites this paper
• Bioinformatics comparison of hemolysin in different bacteria and experimental evaluation of anti-cancer properties of extracts of some hemolysin-producing bacteria.

  2024cites this paper
• Role of the microbiota in response to and recovery from cancer therapy

  2023cites this paper
• Build-a-bug workshop: Using microbial-host interactions and synthetic biology tools to create cancer therapies.

  2023cites this paper
• Synergistic cancer immunotherapy utilizing programmed Salmonella typhimurium secreting heterologous flagellin B conjugated to interleukin-15 proteins.

  2023cites this paper
• Bacterial‐Mediated Tumor Therapy: Old Treatment in a New Context

  2023cites this paper
• Tumor-targeted delivery of lnc antisense RNA against RCAS1 by live-attenuated tryptophan-auxotrophic Salmonella inhibited 4T1 breast tumors and metastasis in mice

  2023cites this paper
• Bacterial cancer therapy using the attenuated fowl-adapted Salmonella enterica serovar Gallinarum

  2023cites this paper
• Salmonella typhimurium may support cancer treatment: a review

  2023cites this paper
• Bacteria-based bioactive materials for cancer imaging and therapy.

  2023cites this paper
• Engineered bacteria for augmented in situ tumor vaccination.

  2023cites this paper
• Hacking the Immune Response to Solid Tumors: Harnessing the Anti-Cancer Capacities of Oncolytic Bacteria

  2023cites this paper
• Culture of attenuated Salmonella Typhimurium VNP20009 in animal-product-free media does not alter schwannoma growth control

  2023cites this paper
• Fundamentals of utilizing microbes in advanced cancer therapeutics: current understanding and potential applications.

  2023cites this paper
• Bacterially mediated drug delivery and therapeutics: strategies and advancements.

  2022cites this paper
• Molecular imaging approaches to facilitate bacteria-mediated cancer therapy.

  2022cites this paper
• A global bibliometric and visualized analysis of bacteria-mediated cancer therapy.

  2022cites this paper
• Targeting primary and metastatic tumor growth in an aggressive breast cancer by engineered tryptophan auxotrophic Salmonella Typhimurium

  2022cites this paper
• Salmonella as a Promising Curative Tool against Cancer

  2022cites this paper
• Recombinant Attenuated Salmonella enterica as a Delivery System of Heterologous Molecules in Cancer Therapy

  2022cites this paper
• Development of a TNF-α-mediated Trojan Horse for Bacteria-based Cancer Therapy.

  2022cites this paper
• Genetically engineered oncolytic bacteria as drug delivery systems for targeted cancer theranostics.

  2021cites this paper
• Recent Progress in the Molecular Imaging of Tumor-Treating Bacteria

  2021cites this paper
• Microbiome in human cancers

  2021cites this paper
• Salmonella typhimurium A1-R Exquisitely Targets and Arrests a Matrix-producing Triple-negative Breast Carcinoma in a PDOX Model

  2021cites this paper
• Customized materials-assisted microorganisms in tumor therapeutics.

  2021cites this paper
• Establishment of an orthotopic prostate cancer xenograft mouse model using microscope-guided orthotopic injection of LNCaP cells into the dorsal lobe of the mouse prostate

  2021cites this paper
• Integration of Salmonella into Combination Cancer Therapy

  2021cites this paper
• Emerging Applications of Bacteria as Antitumor Agents.

  2021cites this paper
• Enhancing the tropism of bacteria via genetically programmed biosensors

  2021cites this paper
• Multidimensional Role of Bacteria in Cancer: Mechanisms Insight, Diagnostic, Preventive and Therapeutic Potential.

  2021cites this paper
• Bacterial cancer therapy in autochthonous colorectal cancer affects tumor growth and metabolic landscape

  2021cites this paper
• Recombinant Methioninase Combined With Tumor-targeting Salmonella typhimurium A1-R Induced Regression in a PDOX Mouse Model of Doxorubicin-resistant Dedifferentiated Liposarcoma

  2020cites this paper
• Imaging of tumor colonization by Escherichia coli using 18F-FDS PET

  2020influential citation
• Recent Advances and Challenges in the Treatment of Rhabdomyosarcoma

  2020cites this paper
• Salmonella Typhimurium as a potential anticancer agent: A Review

  2020cites this paper
• Current Status and Perspectives of Patient-Derived Models for Ewing’s Sarcoma

  2020cites this paper
• Microbes as Medicines: Harnessing the Power of Bacteria in Advancing Cancer Treatment

  2020cites this paper
• Attenuated Salmonella typhimurium cancer therapy has direct effects on the tumor epithelium in colorectal cancer

  2019cites this paper
• Salmonella Typhimurium as an Anticancer Therapy: Recent Advances and Perspectives

  2019cites this paper
• Exquisite Tumor Targeting by Salmonella A1-R in Combination with Caffeine and Valproic Acid Regresses an Adult Pleomorphic Rhabdomyosarcoma Patient-Derived Orthotopic Xenograft Mouse Model

  2019cites this paper
• Longitudinal Visualization of Viable Cancer Cell Intratumoral Distribution in Mouse Models Using Oatp1a1-Enhanced Magnetic Resonance Imaging

  2019cites this paper
• Methioninase Cell-Cycle Trap Cancer Chemotherapy.

  2019cites this paper
• Salmonella-Mediated Cancer Therapy: An Innovative Therapeutic Strategy

  2019cites this paper
• Therapeutische mogelijkheden van het microbioom volop in ontwikkeling

  2019cites this paper
• Long-term response of metastatic renal clear cell carcinoma following a subcutaneous injection of mixed bacterial vaccine: a case report

  2019cites this paper
• Genetically engineered Salmonella Typhimurium: Recent advances in cancer therapy.

  2019cites this paper
• Efficacy of Recombinant Methioninase (rMETase) on Recalcitrant Cancer Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models: A Review

  2019cites this paper
• Efficacy of Tumor-Targeting Salmonella typhimurium A1-R against Malignancies in Patient-Derived Orthotopic Xenograft (PDOX) Murine Models

  2019cites this paper
• Bacterial Targeting of Tumors

  2019cites this paper
• Tumor targeting Salmonella typhimurium A1-R in combination with gemcitabine (GEM) regresses partially GEM-resistant pancreatic cancer patient-derived orthotopic xenograft (PDOX) nude mouse models

  2018cites this paper
• Tumor-targeting Salmonella typhimurium A1-R suppressed an imatinib-resistant gastrointestinal stromal tumor with c-kit exon 11 and 17 mutations

  2018cites this paper
• Cell mass-dependent expression of an anticancer protein drug by tumor-targeted Salmonella

  2018cites this paper
• Enteric Bacterial Regulation of the Wnt/β-Catenin Signaling

  2018cites this paper
• Construction of Bacteria-Based Cargo Carriers for Targeted Cancer Therapy.

  2018cites this paper
• Salmonella-Mediated Cytolethal Distending Toxin Transfer Inhibits Tumor Growth

  2018cites this paper
• Tumor‐Targeting Salmonella typhimurium A1‐R Promotes Tumoricidal CD8+ T Cell Tumor Infiltration and Arrests Growth and Metastasis in a Syngeneic Pancreatic‐Cancer Orthotopic Mouse Model

  2018cites this paper
• University of Groningen High Resolution In Vivo Bioluminescent Imaging for the Study of Bacterial Tumour Targeting

  2018cites this paper
• Tumour-targeting bacteria engineered to fight cancer

  2018cites this paper
• Recent progress in bacterial-mediated cancer therapy

  2018cites this paper
• Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: decoy, trap and kill chemotherapy moves toward the clinic

  2018cites this paper
• Attenuated Salmonella VNP20009 mutant (ΔhtrA) is a promising candidate for bacteria‐mediated tumour therapy in hosts with TNFR1 deficiency

  2018cites this paper
• Infection by Salmonella enterica Promotes or Demotes Tumor Development

  2018cites this paper
• Tumor-targeting Salmonella typhimurium A1-R Inhibits Osteosarcoma Angiogenesis in the In Vivo Gelfoam® Assay Visualized by Color-coded Imaging.

  2018cites this paper
• Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated Salmonella enterica

  2018cites this paper
• Alive attenuated Salmonella as a cargo shuttle for smart carrying of gold nanoparticles to tumour hypoxic regions

  2018cites this paper
• Salmonella mediated the hemagglutinating virus of Japan-envelope transfer suppresses tumor growth

  2017cites this paper
• Salmonella-Mediated Cancer Therapy: Roles and Potential

  2017cites this paper
• Effect of Salmonella enterica serovar Typhimurium VNP20009 and VNP20009 with restored chemotaxis on 4T1 mouse mammary carcinoma progression

  2017cites this paper
• Synthetic biology strategies towards the development of new bioinspired technologies for medical applications

  2017cites this paper
• Patient-Derived Orthotopic Xenograft (PDOX) Models of Melanoma †

  2017cites this paper
• Tumor rim cells: From resistance to vascular targeting agents to complete tumor ablation

  2017cites this paper
• Use of Patient-Derived Orthotopic Xenografts (PDOX) to Evaluate Transformative Cancer Therapeutics

  2017cites this paper
• The irony of highly-effective bacterial therapy of a patient-derived orthotopic xenograft (PDOX) model of Ewing's sarcoma, which was blocked by Ewing himself 80 years ago

  2017cites this paper
• Toxicology and efficacy of tumor-targeting Salmonella typhimurium A1-R compared to VNP 20009 in a syngeneic mouse tumor model in immunocompetent mice

  2017cites this paper
• Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy

  2017cites this paper
• Optimizing the restored chemotactic behavior of anticancer agent Salmonella enterica serovar Typhimurium VNP20009.

  2017cites this paper
• Intra-arterial administration of tumor-targeting Salmonella typhimurium A1-R regresses a cisplatin-resistant relapsed osteosarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model

  2017cites this paper
• Potential usefulness of Brevibacillus for bacterial cancer therapy: intratumoral provision of tumor necrosis factor-α and anticancer effects

  2017cites this paper
• Toxicology and efficacy of tumor-targeting Salmonella typhimurium A1-R compared to VNP 20009 in a syngeneic mouse tumor model in immunocompetent mice.

  2017cites this paper
• Salmonella typhimurium A1-R targeting of a chemotherapy-resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib or temozolomide

  2017cites this paper
• Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin

  2017cites this paper
• Patient-Derived Mouse Models of Cancer

  2017cites this paper
• Modulation of Salmonella Tumor-Colonization and Intratumoral Anti-angiogenesis by Triptolide and Its Mechanism

  2017cites this paper
• Anti-tumor activity of an immunotoxin (TGFα-PE38) delivered by attenuated Salmonella typhimurium

  2017cites this paper